Adicet Bio, Inc. (ACET)

Adicet Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	29.1	56.5	159.71	257.66	277.54	84.33
Short-Term Investments	74	119.81	-	-	-	10.28
Cash & Short-Term Investments	103.1	176.3	159.71	257.66	277.54	94.61
Cash Growth	-48.98%	10.39%	-38.01%	-7.17%	193.34%	51.63%
Accounts Receivable	-	-	-	-	0.19	-
Other Receivables	0.17	-	-	0.44	0.03	2.73
Receivables	0.17	-	-	0.44	0.21	2.73
Prepaid Expenses	3.23	3.83	2.56	2.95	4.68	2.76
Other Current Assets	-	-	-	-	-	0.23
Total Current Assets	106.49	180.14	162.27	261.04	282.44	100.34
Property, Plant & Equipment	30.97	36.75	44.2	48.98	35	25.86
Goodwill	-	-	-	19.46	19.46	20.09
Other Intangible Assets	-	-	-	-	-	1.19
Other Long-Term Assets	3.01	3.33	0.82	1.21	2.04	6.36
Total Assets	140.48	220.22	207.3	330.69	338.94	153.84
Accounts Payable	4.29	4.83	2.63	4.4	3.26	1.55
Accrued Expenses	11.39	11.43	13.44	12.81	6.68	5.73
Current Portion of Leases	3.27	3.13	3.22	2.49	1.57	1.22
Current Unearned Revenue	-	-	-	-	4.81	13.98
Total Current Liabilities	18.94	19.39	19.29	19.71	16.32	22.48
Long-Term Leases	12.27	14.1	17.7	18.53	19.38	20.42
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.13
Other Long-Term Liabilities	0.13	0.12	0.13	0.11	0.12	0.98
Total Liabilities	31.34	33.61	37.12	38.35	35.81	44.01
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	693.26	684.48	550.94	530.45	471.45	216.13
Retained Earnings	-584.18	-497.89	-380.77	-238.11	-168.32	-106.33
Comprehensive Income & Other	0.06	0.02	-	-	-	0.02
Total Common Equity	109.14	186.61	170.18	292.34	303.13	109.83
Shareholders' Equity	109.14	186.61	170.18	292.34	303.13	109.83
Total Liabilities & Equity	140.48	220.22	207.3	330.69	338.94	153.84
Total Debt	15.54	17.23	20.92	21.02	20.94	21.64
Net Cash (Debt)	87.56	159.07	138.79	236.63	256.6	72.98
Net Cash Growth	-52.38%	14.61%	-41.35%	-7.78%	251.63%	-0.02%
Net Cash Per Share	0.95	1.81	3.22	5.76	8.29	9.97
Filing Date Shares Outstanding	161.7	91.13	90.6	42.95	39.88	31.78
Total Common Shares Outstanding	91.7	91.01	43.27	42.95	39.74	19.68
Working Capital	87.55	160.74	142.99	241.33	266.12	77.86
Book Value Per Share	1.19	2.05	3.93	6.81	7.63	5.58
Tangible Book Value	109.14	186.61	170.18	272.88	283.67	88.55
Tangible Book Value Per Share	1.19	2.05	3.93	6.35	7.14	4.50
Machinery	14.85	15	14.31	7.86	6.02	4.97
Construction In Progress	0.2	0.2	0.27	9.29	13.01	1.09
Leasehold Improvements	28.42	28.23	26.64	19.96	1.61	1.43

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q